Andrew E. Place, Ph.D.
Affiliations: | 2004 | Dartmouth College, Hanover, NH, United States |
Area:
PharmacologyGoogle:
"Andrew Place"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael B. Sporn | grad student | 2004 | Dartmouth | |
| (Pre-clinical evaluation of the novel synthetic triterpenoid CDDO-imidazolide.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pikman Y, Tasian SK, Sulis ML, et al. (2021) Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-risk Leukemias: A Report from the LEAP Consortium. Cancer Discovery |
| Goldsmith KC, Verschuur A, Morgenstern DA, et al. (2020) The first report of pediatric patients with solid tumors treated with venetoclax. Journal of Clinical Oncology. 38: 10524-10524 |
| Karol SE, Cooper TM, Bittencourt H, et al. (2019) Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Phase 1 Study Blood. 134: 2649-2649 |
| Shulman DS, Vo KT, Fox E, et al. (2019) Abstract CT112: A Phase I multicenter trial of the dual MDM2/MDMX inhibitor ALRN-6924 in children and young adults with relapsed/refractory pediatric cancers Cancer Research. 79 |
| Place AE, Pikman Y, Stevenson KE, et al. (2018) Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. e27062 |
| Place AE, Goldsmith K, Bourquin JP, et al. (2018) Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies. Future Oncology (London, England) |
| Gore L, Kearns PR, de Martino Lee ML, et al. (2018) Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017759597 |
| Sun W, Triche T, Malvar J, et al. (2018) A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from TACL consortium. Blood |
| Place AE, Blonquist TM, Stieglitz E, et al. (2018) Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia Blood. 132: 1405-1405 |
| Townsend EC, Murakami MA, Christodoulou A, et al. (2016) The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 29: 574-86 |